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ABSTRACT 
Introduction and Objectives: In this study, we aimed to investigate whether platelet 
count (PLT) and platelet indices included mean platelet volume (MPV), platecrit (PCT), 
platelet distribution width (PDW) values can be used as diagnostic markers in cranial 
meningiomas. 
Materials and Methods: The study included results of 29 patient and 47 healthy 
contributors. Based on pathologies, the patients were divided into two groups. The 
first group included meningioma patients and the second one included healthy 
individuals. Healthy contributors named control group. Platelet count and platelet 
indices were determined using Sysmex XN 550 haematology analyzer. The 
preoperative platelet count (PLT) and platelet indices included mean platelet volume 
(MPV), platecrit (PCT), platelet distribution width (PDW) values were recorded from 
the routine laboratory tests. 
Results: There was no statistically significant difference in PLT between the 
meningioma and healthy groups (p = 0.217). There was a statistically significant 
difference in PCT between the meningioma group and the healthy group (p = 0.002). 
There was a statistically significant difference in PDW between meningioma group 
and healthy group (p = 0.001). In terms of MPV, there was a statistically significant 
difference between meningioma group and the healthy group (p = 0.001) 
Conclusion: Platelet count and indices are easily available in the routine blood tests. 
Despite the retrospective design and small sample size, our findings suggest that 
altered MPV, PDW and PCT levels might serve as potential biomarkers for the 
diagnosis of meningiomas. 
 
 
INTRODUCTION 
Platelets are reproduced from megakaryocytes1. We know that platelets 
play an important role in the coagulation process. Platelets have been 
studied for many years for their vital role in tumorigenesis. Many 
different mechanisms of the relationship between cancer cells and 
platelets have been demonstrated. Newly, platelets were declared to 
be associated with the development and progression of malignan- 
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cies2.3. The relation between cancer and 
inflammation was identified in the last century. As 
known, neutrophils, and lymphocytes are 
responsible for inflammation. New studies reported 
that platelets play a major role in inflammation4,5. 
Platelets are the first to accumulate at the site of 
damage and they secrete proinflammatory and 
growth factors such as platelet activated factor (PAF), 
vascular endothelial growth factor (VEGF), platelet 
derivate growth factor (PDGF), and thromboxane A2 
at the injured area. VEGF plays a key role in 
regulating angiogenesis via increasing vascular 
permeability and facilitating the branching and 
formation of new blood vessels in the tumor site 
6.Meningioma is a central nervous system tumor 
arising from the arachnoid cells present in the 
arachnoid mater. It is the most common benign 
primary tumor of the brain. Currently, there is still no 
consensus for biomarkers that can be used for early 
diagnosis and prognosis for meningiomas. In this 
study, we used platelet indices for the search of 
potential biomarkers for meningiomas. 
 
MATERIALS AND METHODS 
The study included results of 29 patient and 47 
healthy contributors. The patients underwent 
surgery. Patients’ laboratory and pathology results 
were retrospectively reviewed from the hospital 
archive. Based on pathologies, the patients were 
divided into two groups. The first group included 
meningioma patients and the second one included 
healthy indivudials. Healthy contributors named 
control group. Platelet count and platelet indices 
were determined using Sysmex XN 550 hematology 
analyzer. The preoperative platelet count (PLT) and 
platelet indices included mean platelet volume 
(MPV), platecrit (PCT), platelet distribution width 
(PDW) values were recorded from the routine 
laboratory tests.  
 
Statistical analysis 
The R 3.2.1 package program was used to analyze 
data. Descriptive statistics of the quantitative 
variables included in the study were determined by 
mean, standard deviation, median, minimum and 
maximum values; qualitative variables are indicated 
by frequency and percentage. The suitability of the 
continuous variables to the normal distribution was 
examined by the Shapiro Wilk test. Mann Whitney U 
test was used to compare two groups of continuous 
variables that do not show normal distribution. The 
relationships between continuous variables were 
interpreted with the Pearson correlation coefficient. 
Pearson chi-square and Yates chi-square tests were 
used to comparing qualitative variables between 
groups. In all statistical analyzes in the study, p values 
less than 0.05 were considered statistically 
significant. 
 
RESULTS  
A total of 76 contributors were included in this study. 
29 of them meningioma patients, and 47 of them 
were healthy contributors. There was no statistically 
significant difference in PLT between the 
meningioma and healthy groups (p = 0.217)(Figure 
1). There was a statistically significant difference in 
PCT between the meningioma group and the healthy 
group (p = 0.002)(Figure 2). There was a statistically 
significant difference in PDW between meningioma 
group and healthy group (p = 0.001)(Figure 3). In 
terms of MPV, there was a statistically significant 
difference between meningioma group and the 
healthy group (p = 0.001)(Figure 4). 
 
 
Figure 1. Comparison of PLT levels between the patients and 
the healthy control group. 
 
 
Figure 2. Comparison of PCT levels between the patients and 
the healthy control group. 
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Figure 3. Comparison of PDW levels between the patients and 
the healthy control group. 
 
 
Figure 4. Comparison of MPV levels between the patients and 
the healthy control group. 
 
DISCUSSION 
Although it is known that genetic factors are essential 
in the development of cancer, the host inflammatory 
response is reported to be very important in the 
underlying mechanism of carcinogenesis 7. Releasing 
inflammatory cytokines and chemokines in the 
damaged areas caused platelet activation. Platelets 
facilitate endothelial adhesion of leukocytes. 
Recently, researchers suggest that platelets act an 
important role in neoplastic disease. They put 
forward that platelets cause encapsulation of 
neoplastic cells and provide them to get out of 
recognition by the host immune system 8,9. 
Meningiomas are the common benign neoplasms of 
the central nervous system. They appear 
approximately 20 percent frequently in all of the 
brain tumors and risk factors for these neoplasms 
are still little known 10. High level of different 
cytokines which is multiple pathways of 
carcinogenesis was found in brain tumor specimens 
11. Platelets increase megakaryocytes and pro-
inflammatory cytokines released by cancer 12. 
In this study, we aimed to measure PLT and it’s 
indices in patient with meningioma, and healthy 
group. PDW values were found significantly lower in 
meningioma group compared to the healthy control 
group but PCT and MPV values were found 
significantly higher in meningioma group compared 
to the healthy control group. Numerous study 
proposes that PLT increases in many cancer types 
also some others propose that no changes in PLT. 
Taucher et al showed that platelet count is 
significantly higher in patients with breast cancer 
compared with the control group 13. Inagaki et al 
found that platelet count is significantly higher in 
patients with non-small cell lung cancer 14. Ma, 
Ozaksit and Okuturlar et al established that there 
were no statistical changes in PLT while compared 
the groups similarly to our study 15, 16, 17. In our study, 
we found no statistical changes in PLT while 
comparing the groups. The average platelet volume 
in the blood mean MPV and heterogeneity in platelet 
volume mean PDW. MPV is generally used for 
determining the platelet activity and function in the 
platelet indices 18. Theoretically, reduction in platelet 
counts causes stimulation of megakaryocytes and 
they are transformed into large platelets 19. Larger 
platelets are more metabolically and enzymatically 
active than smaller platelets 20. Cho et al. found that 
patients with hepatocellular carcinoma had higher 
MPV. In our study, we found statistical higher MPV 
level in meningioma patients compared to the 
healthy group. Inagaki N and Kumagai S et al. 
showed that the patients had non-small cell lung 
cancer with poor prognosis had low MPV levels 14, 21. 
There are different results in PDW in many research. 
Inagaki et al. found lower PDW levels similarly our 
study in non-small cell lung cancer 14. Okuturlar et al. 
showed no statistical difference between breast 
cancer patients and the healthy groups in PDW 17. Ma 
et al. found that increase PDW levels in epithelial 
ovarian cancer 15. Xuegong et al. have established 
that the level of PCT is higher in patients with 
epithelial ovarian cancer compared to the healthy 
group 22. Ozaksit et al. showed that there is no 
difference between the malignant and benign 
ovarian masses and the control group in terms of 
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PCT values 16. We found statistical lower levels of PCT 
in meningioma patients compared with the healthy 
group. 
 
CONCLUSION 
We suggest that the usability of PLT and indices in the 
early diagnosis of meningioma patients and should 
be researched by further studies that have larger 
populations diagnosed with meningioma and their 
grades. 
 
 
REFERENCES 
1. George JN. Platelets. Lancet. 2000;355(9214):1531–1539. 
2.  Franco, A. T. Corken, A. & Ware, J. Platelets at the interface 
of thrombosis, inflammation, and cancer. Blood 126, 
582–588, https:// doi.org/10.1182/blood-2014-08-531582 
(2015). 
3.  Buergy, D. Wenz, F. Groden, C. & Brockmann, M. A. 
Tumor-platelet interaction in solid tumors. Int J Cancer 
130, 2747–2760, https://doi.org/10.1002/ijc.27441 (2012). 
4.  Balkwill F. & Mantovani A. Inflammation and cancer: back 
to Virchow? Lancet. 2001;357:539-45. 
5.  Tozkoparan E, Deniz O, Ucar E, et al. Changes in platelet 
count and indices in pulmonary tuberculosis. Clin Chem 
Lab Med. 2007;45:1009-13. 
6.  Cai J, Ma H, Huang F, et al (2013). Correlation of 
bevacizumab induce hypertension and outcomes of 
metastatic colorectal cancer patients treated with 
bevacizumab: a systematic review and meta-analysis. 
World J Surg Oncol, 11, 306. 
7.  Coupland LA, Parish CR (2014). Platelets, selectins, and 
the control of tumor metastasis. Semin Oncol, 41, 422-34. 
8.  M. R. Barnard, L. A. Krueger, A. L. Frelinger III, M. I. 
Furman, and A. D. Michelson, “Whole blood analysis of 
leukocyte-platelet aggregates,” Current Protocols in 
Cytometry, 2003. 
9.  R. Leblanc and O. Peyruchaud, “Metastasis: new 
functional implications of platelets and megakaryocytes,” 
Blood, vol. 128, no. 1, pp. 24–31, 2016. 
10.  Sergentanis TN, Tsivgoulis G, Perlepe C, Ntanasis-
Stathopoulos I, Tzanninis IG, Sergentanis IN, 
Psaltopoulou T. Obesity and Risk for Brain/CNS Tumors, 
Gliomas and Meningiomas: A Meta-Analysis. PLoS One. 
2015;10:e0136974. [PMC free article] [PubMed] [Google 
Scholar] 
11.  Albulescu, R.; Codrici, E.; Popescu, I.D.; Mihai, S.; Necula, 
L.G.; Petrescu, D.; Teodoru, M.; Tanase, C.P. Cytokine 
patterns in brain tumor progression. Mediat. Inflamm. 
2013, 2013, 979748. [CrossRef] [PubMed] 
12.  Mutlu H, Artis TA, Erden A, Akca Z. Alteration in Mean 
Platelet Volume and Platicrit Values in Patients With 
Cancer That Developed Thrombosis. Clin Appl Thromb 
Hemost. 2013;19:331-3. 
13.  Taucher S, Salat A, Gnant M, Kwasny W, Mlineritsch B, et 
al. (2003) Impact of pretreatment thrombocytosis on 
survival in primary breast cancer. Thromb Haemost 
89(6): 1098-1106. 
14. Inagaki N, Kibata K, Tamaki T, et al (2014). Prognostic 
impact of the mean platelet volume/platelet count ratio 
in terms of survival in advanced non-small cell lung 
cancer. Lung Cancer, 83, 97-101. 
15.  Ma X, Wang Y, Sheng H, et al (2014). Prognostic 
significance of thrombocytosis, platelet parameters and 
aggregation rates in epithelial ovarian cancer. J Obstet 
Gynaecol Res, 40, 178-83. 
16.  Ozaksit G, Tokmak A, Kalkan H, et al (2015).Value of the 
platelet to lymphocyte ratio in the diagnosis of ovarian 
neoplasms in adolescents. Asian Pac J Cancer Prev, 16, 
2037-41. 
17.  Okuturlar Y, Gunaldi M, Tiken EE, et al (2015). Utility of 
peripheral blood parameters in predicting breast cancer 
risk. Asian Pac J Cancer Prev, 16, 2409-12. 
18.  Gasparyan AY, Ayvazyan L, Mikhailidis DP, Kitas GD. Mean 
platelet volume: a link between thrombosis and 
inflammation? Curr Pharm Des. 2011;17(1):47–58. 
19.  Alsweedan SA, Al-Shurman A, Mahmoud AS (2008). 
Diagnostic value of platelet indices in children with 
leukemia. J Pediatr Hematol Oncol, 30, 953-5. 
20.  Kannar V, Raja V, Suresh TN (2017) Evaluation of platelet 
indices in oral squamous cell carcinoma. Clin Cancer 
Investig J 6(1): 40-43. 
21.  Kumagai S, Tokuno J, Ueda Y, Marumo S, Shoji T, 
Nishimura T, Fukui M, Huang CL. Prognostic significance 
of preoperative mean platelet volume in resected non-
small cell lung cancer. Mol Clin Oncol. 2015;3:197-201. 
22.  Xuegong Ma, Yingmei Wang, Hongna Sheng, Wenyan 
Tian, Zheng Qi, Fei Teng, Fengxia Xue. Prognostic 
significance of thrombocytosis, platelet parameters and 
aggregation rates in epithelial ovarian cancer. Journal of 
Obstetrics and Gynaecology Research 2014, 40 (1): 178-
83. 
   
 
 
 
